Rob Hershberg
Director (Nominating and Corporate Governance Committee, Member; Science and Technology Committee, Member) at atai Life Sciences
About
Rob Hershberg is Co-Founder, President, CEO and board chairman of HilleVax, and a Venture Partner with Frazier Healthcare Partners, where he has worked with the firm and its portfolio companies for 14 years. He previously co-founded and led VentiRx Pharmaceuticals, and held senior roles at Celgene (including Chief Scientific Officer and Head of Business Development & Global Alliances), Dendreon, and Corixa. He earned his undergraduate and medical degrees at UCLA and a Ph.D. from the Salk Institute, and previously served as an assistant professor at Harvard Medical School.
Invests in
Biotech
Colleagues at atai Life Sciences
Amir Kalali
Director at atai Life Sciences
Andrea Heslin Smiley
Director at atai Life Sciences
Anne Johnson
Chief Accounting Officer at atai Life Sciences
Christian Angermayer
Founder and Chairman of the Board at atai Life Sciences
Gerd Kochendoerfer
Chief Operating Officer at atai Life Sciences
Glenn Short
Chief Scientific Officer at atai Life Sciences
John Hoffman
Director at atai Life Sciences
Kevin Craig
Chief Medical Officer at atai Life Sciences